1. A phase I pharmacokinetic study of belinostat in patients with advanced cancers and varying degrees of liver dysfunction. Issue 11 (4th September 2019) Authors: Takebe, Naoko; Beumer, Jan H.; Kummar, Shivaani; Kiesel, Brian F.; Dowlati, Afshin; O'Sullivan Coyne, Geraldine; Piekarz, Richard; Rubinstein, Lawrence; Fogli, Laura K.; Vaishampayan, Ulka; Goel, Sanjay; O'Bryant, Cindy L.; El‐Rayes, Bassel F.; Chung, Vincent; Lenz, Heinz‐Josef; Kim, Richard; Bel... Journal: British journal of clinical pharmacology Issue: Volume 85:Issue 11(2019) Page Start: 2499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A Phase I Study of Ganetespib and Ziv‐Aflibercept in Patients with Advanced Carcinomas and Sarcomas. (4th June 2018) Authors: Meehan, Robert; Kummar, Shivaani; Do, Khanh; O'Sullivan Coyne, Geraldine; Juwara, Lamin; Zlott, Jennifer; Rubinstein, Larry; Doroshow, James H.; Chen, Alice P. Journal: Oncologist Issue: Volume 23:Number 11(2018) Page Start: 1269 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Cediranib phase‐II study in children with metastatic alveolar soft‐part sarcoma (ASPS). Issue 12 (10th September 2019) Authors: Cohen, Julia W.; Widemann, Brigitte C.; Derdak, Joanne; Dombi, Eva; Goodwin, Anne; Dompierre, Jessica; Onukwubiri, Uzoma; Steinberg, Seth M.; O'Sullivan Coyne, Geraldine; Kummar, Shivaani; Chen, Alice P.; Glod, John Journal: Pediatric blood & cancer Issue: Volume 66:Issue 12(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Class act: safety comparison of approved tyrosine kinase inhibitors for non-small-cell lung carcinoma. (January 2015) Authors: Burotto, Mauricio; Ali, Syed Abbas; O'Sullivan Coyne, Geraldine Journal: Expert opinion on drug safety Issue: Volume 14:Number 1(2015:Jan.) Page Start: 97 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Clinical experience with ramucirumab: outcomes in breast cancer. (September 2014) Authors: O'Sullivan Coyne, Geraldine; Burotto, Mauricio Journal: Expert opinion on biological therapy Issue: Volume 14:Number 9(2014:Sep.) Page Start: 1351 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Delivering on the promise: poly ADP ribose polymerase inhibition as targeted anticancer therapy. Issue 6 (November 2015) Authors: O'Sullivan Coyne, Geraldine; Chen, Alice; Kummar, Shivaani Journal: Current opinion in oncology Issue: Volume 27:Issue 6(2015:Nov.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma. Issue 1 (21st October 2019) Authors: Rajan, Arun; Heery, Christopher R.; Thomas, Anish; Mammen, Andrew L.; Perry, Susan; O'Sullivan Coyne, Geraldine; Guha, Udayan; Berman, Arlene; Szabo, Eva; Madan, Ravi A.; Ballester, Leomar Y.; Pittaluga, Stefania; Donahue, Renee N.; Tsai, Yo-Ting; Lepone, Lauren M.; Chin, Kevin; Ginty, Fiona; Soo... Journal: Journal for immunotherapy of cancer Issue: Volume 7:Issue 1(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Immune play: defending the liver. (January 2015) Authors: O'Sullivan Coyne, Geraldine; Greten, Tim F Journal: Hepatic oncology Issue: Volume 2:Number 1(2015) Page Start: 15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. MABp1 for the treatment of colorectal cancer. (2nd September 2017) Authors: O'Sullivan Coyne, Geraldine; Burotto, Mauricio Journal: Expert opinion on biological therapy Issue: Volume 17:Number 9(2017:Sep.) Page Start: 1155 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Molecular Profiling-Based Assignment of Cancer Therapy (NCI-MPACT): A Randomized Multicenter Phase II Trial. (12th January 2021) Authors: Chen, Alice P.; Kummar, Shivaani; Moore, Nancy; Rubinstein, Lawrence V.; Zhao, Yingdong; Williams, P. Mickey; Palmisano, Alida; Sims, David; O'Sullivan Coyne, Geraldine; Rosenberger, Christina L.; Simpson, Mel; Raghav, Kanwal P. S.; Meric-Bernstam, Funda; Leong, Stephen; Waqar, Saiama; Foster, Ja... Journal: JCO precision oncology Issue: Volume 5(2021) Page Start: 133 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗